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Abstract
Diabetes mellitus currently affects 8.3% of the world’s population, roughly 387 
million people as of 2014, with numbers rising steadily. Diabetes is a major risk factor for 
vascular pathology, affecting the vascular wall at the cellular and extracellular level. The 
field of tissue engineering has proven to have great potential in treating cardiovascular 
disease and kidney failure. In order to develop tissue-engineered replacements resistant to 
the alterations induced by a diabetic environment, the modifications of the native tissues 
are important to be elucidated.  
Cardiovascular remodeling is due to elevated levels of fatty deposits along the 
vessel wall, hyperglycemia and chronic inflammation. The major vascular matrix 
components, such as collagen and elastin, interact irreversibly with the elevated levels of 
blood glucose and lipids via oxidation and crosslinking processes resulting in the 
formation of advanced glycation end products and vascular stiffening. Adventitial 
fibroblasts, the “first-responder” to vascular injury, are involved in normal maintenance 
of blood vessels, contributing to repair and remodeling. Adventitial fibroblasts play an 
active role in the arterial response to injury, cytokines and stretch, which stimulate their 
activation and differentiation into myofibroblasts.  
Diabetes is also the most common cause of chronic renal disorders and end stage 
renal disease. Diabetes results in a wide range of alterations in renal tissue such as 
glomerular sclerotic lesions, hypertrophy of glomeruli, tubulointerstitial fibrosis, 
increased expression of myofibroblasts and inflammation that contribute to kidney 
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dysfunction and diabetic nephropathy. The aim of this study was to show the histological 
changes of renal tissue associated with diabetes with an emphasis on remodeling of the 
renal vasculature. 
Kidney samples were explanted at a time point 3 months from diabetic and non-
diabetic rats and were histologically analyzed for indications of pathological remodeling. 
The sample cross sections were stained and analyzed for early signs of diabetic 
nephropathy including glomerulus deterioration, vessel wall remodeling, and vascular 
cell dyfunction. This was done using hematoxylin & eosin, Masson’s trichrome, periodic 
acid schiff and various immunostainings for α-SMA, CD146, CD68, von Willebrand 
factor and collagen type IV. Dense perivascular collagen deposition could be seen under 
diabetic conditions. Increased macrophage infiltration was observed in diabetics as well 
as increased pericyte and endothelial cell expression suggesting upregulation of 
angiogenesis and increased remodeling and repair within the kidney. Myofibroblast 
activity, the main contributing cell to organ fibrosis, was upregulated in diabetics 
showing early signs of kidney fibrosis – a common outcome in diabetic nephropathy.  
In conclusion, determining the modifications induced by diabetes at a vascular 
cell and extracellular level could lead to finding optimal treatments for renal artery 
disease and improved kidney tissue engineering approaches.  
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1 Introduction 
The kidneys are paired organs that are primarily involved in the urinary system, 
but also associated with several other bodily systems, including the cardiovascular and 
endocrine system. They play a critical role in a variety of physiological functions 
including the excretion of waste products, elimination of foreign substances, regulation of 
blood pressure and total body water, control of acid-base balance and regulation of bodily 
salts concentration. In order to perform these functions, the kidneys are highly 
vascularized and receive a significant amount of blood flow 1. Because of this high 
amount of blood flowing in and out of the kidney, the cardiovascular system and the 
kidneys are acutely dependent on each other, and kidney dysfunction can exacerbate and 
accelerate cardiovascular disease 2. 
The vascular system is a dense network of blood vessels carrying nutrients, gases 
and waste products to their respective destinations. While they range in size, mechanical 
properties and functionality, the general composition of blood vessels remains the same 
throughout the vasculature. Vessels are composed of cellular constituents, such as 
endothelial cells, fibroblasts and smooth muscle cells (SMCs), and extracellular matrix 
proteins, primarily consisting of collagen and elastin. These basic constituents are 
typically arranged in three concentric layers: intima, media and adventitia (Fig. 1, 2), 
each serving a distinct mechanical and biological function 3. It is essential to understand 
the mechanics and functionality of the vascular wall to attempt to closely mimic these 
characteristics of native vessels when conceptualizing a replacement vascular graft, as an 
ideal substitute should mimic the native vessels as closely as possible. 
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Figure 1: Diagram of the basic structure of an artery, including the intima with an 
endothelial layer and basement membrane, the media consisting of a heavy population of 
SMCs is between the internal and external elastic lamina, and the adventitia is shown 
with a concentration of collagen with scattered cells. (From Kumar, et al. 8th ed., 2010) 
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Figure 2: Micrograph of a cross section of a porcine renal artery. The three layers of the 
vascular wall are clearly defined. The intima is simply the epithelial layer lining the 
lumen. The media is the mostly red section with smooth muscle staining red. The thick 
collagen (blue) deposits can be seen in the adventitia with spare amounts in the media. 
(Masson’s Trichrome (MT) & Verhoeff Van Gieson (VVG) Staining, 100X) 
 
1.1 Blood Vessel Structure 
 
1.1.1 Intima 
 The intima, the innermost layer of the blood vessel, is a thin layer of cells that 
coats the internal lumen of the vessel along with a surrounding basement membrane. The 
intima consists of a layer of simple squamous endothelial cells, which line the entire 
luminal surface of every vessel in the vascular system with a limited amount of elastic 
4 
 
fibers restraining the cells to the vessel wall 3. Endothelial cells are multifunctional cells 
mediating hemostasis, neutrophil recruitment and hormone trafficking but their primary 
function is controlling the flow of materials and white blood cells into and out of the 
bloodstream 4,5. These cells regulate the flow of materials based upon local environments 
and adjust their arrangement and concentration to adapt to local needs. When a 
population of cells is becoming hypoxic, they increase their production of the 
transcription factor hypoxia-inducible factor 1, which stimulates the production of 
vascular endothelial growth factor (VEGF). VEGF stimulates endothelial cells to 
proliferate and invade hypoxic tissue allowing angiogenesis to occur and subsequently 
resupply oxygen to the tissue 5. Angiogenesis is continuously occurring to support 
recurrent cycles of remodeling and in needs of repair where tissue damage is present 6,5. 
Despite a low turnover rate and a long lifetime, endothelial cells have the ability to 
proliferate and migrate in the event of vascular injury where they serve a critical role in 
vascular repair 5.  
 Pericytes are a heterogeneous group of extensively branched cells attached to the 
abluminal side of microvessels throughout the vasculature that are crucial for vascular 
homeostasis. These cells are embedded in the intimal basement membrane and 
interdigitate between the luminal endothelial cells 7. Pericytes are multifunctional cells 
positioned within capillaries and postcapillary venules that contribute in physiological 
processes including vessel stabilization, regulation of vascular tone and blood flow, 
maintenance of local tissue homeostasis, synthesis of extracellular matrix (ECM), 
progenitor cell functions and participation in repair and inflammation 7,8. These cells are 
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considered heterogeneous due to their variations in functionality, morphology, origin and 
location within the body 8.  
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Figure 3: A magnified view of the blood vessel layer. (A) The intima is separated from 
the media by a thin layer of elastin (black). The smooth muscle (red) is the main 
component of the media with sparse collections of collagen (blue) scattered throughout. 
(B) Shows the transition from the media to the adventitia with the external elastic 
membrane separating the two layers. The black dots scattered throughout the adventitia 
are adventitial fibroblasts. (MT-VVG, 200X) 
 
1.1.2 Media 
 The media is the middle layer of the blood vessel wall and typically the thickest 
layer in arteries. It consists of concentric sheets of smooth muscle tissue, composed 
primarily of SMCs supported by loose connective tissue (Fig. 3) 6. The principal function 
of vascular SMCs is contractile movement as they respond to local conditions and 
sympathetic or endocrine stimulation and adjust the luminal diameter to control local 
blood flow 9. These cells express isoforms of contractile proteins, specifically actin, that 
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allow the contractile action to occur. The most abundant of these isoforms is α-smooth 
muscle actin (α-SMA). In arteries, the media is separated from the outer most layer, the 
adventitia, by the external elastic membrane 6.  
 
Figure 4: Diagram of the shape SMCs take in their relaxed state and in contracted state 
with actin and myosin action. (From Martini, et al. 9th edition, 2012) 
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1.1.3 Adventitia 
 The adventitia is a collagenous sheath with scattered fibroblasts that encompasses 
the vascular wall providing strength and stability by anchoring the blood vessel to 
surrounding tissue. Adventitial fibroblasts are the main cell type within this layer and 
become suspended within the ECM they have deposited. Additionally, the media and 
adventitia incorporate a network of small arterioles called the vasa vasorum that supplies 
blood to the cells on the blood vessel 6. 
 
1.2 Arterial Blood Flow 
 Each of these various components and layers serve specific functions within the 
blood vessel, and the composition of a blood vessel varies based on its distance away 
from the heart. These structural variations are mainly confined to the media and the 
extracellular matrix while the intima remains consistent across all blood vessels 3. 
Arteries are divided into three categories: elastic arteries, muscular arteries and arterioles. 
Elastic arteries, also known as conducting arteries, are large arteries carrying a high 
volume of blood away from the heart such as the aorta and pulmonary arteries 3. With its 
high content of elastin and few SMCs, the walls of elastic arteries are extremely resilient 
and can withstand the pulsatile flow and pressure fluctuations exerted during the cardiac 
cycle 6. During ventricular systole, the aorta expands to manage the high pressure and 
stroke volume then recoils during diastole to propel blood to the peripheral arteries 3. 
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Elastic arteries are large enough to sustain these hemodynamic forces with lumen 
diameters up to 2.5 cm. Elastic arteries distribute blood to muscular arteries, which 
supply the body’s skeletal muscles and internal organs 6. Muscular arteries, such as the 
mesenteric arteries and renal artery, are principally characterized by their thick media 
layer of SMCs. Smooth muscle contraction and relaxation allows the muscular arteries to 
control regional blood pressure and blood flow by actively changing the lumen size 3. 
Muscular arteries range in size from 4.0 mm to 0.5 mm in internal diameter while 
arterioles are 30 μm or less. Arterioles have a poorly defined adventitia and the media 
ranges from one or two layers of smooth muscles cells to as little as a scattered number of 
cells not forming a full layer in the smallest arterioles 6. Arterioles transition into the 
capillaries, consisting of only endothelial cells, where nutrient exchange occurs before 
proceeding into the venous system. Pericytes are present within the basement membrane 
of these microvessels that extend into the endothelium of the vessel and control local 
blood flow through the capillaries and venules 8. 
 
1.3 Blood Vessel Pathology 
 
1.3.1 Cellular Responses to Pathological Conditions 
 While the cellular components of the blood vessels play an essential role in the 
functionality of vascular wall, they are also critical in pathological processes of the 
vasculature. Under pathophysiologic conditions, vascular cells respond to their 
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environment and pro-inflammatory signaling, which disrupts their normal functionality 
and significantly increases the risk of cardiovascular diseases. Blood vessels respond to 
hypertension, dyslipidemia, hyperglycemia, oxidative stress and chronic inflammation. 
Vascular remodeling, called arteriogenesis, is induced in response to chronic changes in 
blood glucose, pressure and flow 3. Atherosclerosis was once thought of as narrowing of 
the arterial lumen through the buildup of fatty plaques; however, there is extensive 
remodeling occurring within the vascular wall that makes the development of the disease 
more complex 10. Upon atherosclerotic lesion formation, the expression of endothelial 
cell adhesion molecules and pro-inflammatory cytokines attract leukocytes, which results 
in accumulation within the vessel wall and progression of lesion formation 11. Vascular 
cells become activated and adjust their normal functions and express newly acquired 
phenotypes under pathophysiologic conditions by a variety of factors including 
cytokines, elevated hemodynamic stresses and lipid content, advanced glycation end 
products (AGEs) and reactive oxygen species (ROS). 
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Figure 5: Pathway of chronic inflammation and the impact of leukocyte activation on 
cellular responses. The release of growth factors and cytokines recruit and stimulate cells 
to alter their phenotype and contribute to tissue damage repair, which involves heavy 
deposition of ECM, specifically collagen. (From Kumar, et al. 8th ed., 2010) 
 
1.3.2 Endothelial Cell Dysfunction 
 Luminal endothelial cells are multifunctional and play a critical role in vessel wall 
homeostasis and circulatory function. The endothelium maintains a non-thrombogenic 
blood-tissue interface that prevents leukocyte adhesion and controls the passage of 
materials into and out of the bloodstream. However, the tight connections of the 
endothelial cells can loosen under pathological stimuli and allow additional materials and 
leukocytes to pass into the vascular wall 3.  
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Figure 6: Diagram of activators and the activator-induced phenotype of endothelial cells. 
(From Kumar, et al. 8th ed., 2010) 
 
 Endothelial cell activation can be induced by pro-inflammatory cytokines that 
promote leukocyte recruitment and attachment to the vessel wall 12. Activated endothelial 
cells express cell-surface adhesion molecules while circulating leukocytes express 
integrins in response to an inflammatory stimulus (Fig. 6) 4,13. As this activated state 
develops, the cells enter a progressive state called endothelial dysfunction where they 
display an altered phenotype. Endothelial dysfunction is defined as a diminished 
production of endothelium-derived nitric oxide (NO) and contributes to cardiovascular 
disease 12,4. Dysfunctional endothelial cells promote developmental mechanisms for 
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atherosclerosis including increased adhesion to inflammatory cells and platelets, initiation 
of thrombus formation and increased ROS. While the cells diminish production of 
vasodilators, mainly NO, they also increase in contracting factors, such as endothelin-1, 
affecting the vasoreactivity of the smooth muscle cells 12,3. Part of the endothelial cells’ 
normal function is to balance these responses, and the underlying SMCs react to these 
imbalanced factors 3.  
Figure 7:  Diagram of NO pathway related to endothelial function. Endothelial nitric 
oxide synthase (eNOS) synthesizes NO within the endothelium and releases it into the 
bloodstream and across the SMCs cellular membrane. NO induces vasodilation of the 
SMCs and reduces leukocyte and platelet adhesion. (From Kumar, et al. 8th ed., 2010) 
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1.3.3 Smooth Muscle Cell Dysfunction 
 Just as the media plays a large role in vascular wall repair and remodeling, SMCs 
play a central role in dysfunctional remodeling. SMCs have the capacity to proliferate 
and migrate if stimulated by growth promoters such as platelet-derived growth factor 
(PDGF), thrombin, endothelin-1, and fibroblast growth factor (FGF). Inhibitors include 
NO and transforming growth factor-β (TGF-β), which are both diminished when vascular 
injury occurs (Fig. 7). Vascular injury or endothelial dysfunction incites SMC migration, 
growth and proliferation, and extracellular matrix synthesis that result in the formation of 
an enlarged intima called a neointima (Fig. 8). The SMCs of the neointima display a 
synthetic phenotype and are considered de-differentiated while losing the ability to 
contract 3.  
 
Figure 8: Schematic diagram of intimal thickening, showing smooth muscle migration to 
the intima, proliferation within the intima and extracellular matrix deposition within the 
neointima. (From Kumar, et al. 8th ed., 2010) 
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1.3.4 Adventitial Fibroblast Dysfunction 
 In the past, the adventitia was considered nothing more than a simple connective 
tissue sheath surrounding the blood vessels without a specialized function other than 
support 14. Most of the research regarding the pathogenesis of atherosclerosis and other 
vascular diseases has been focused around intima and media dysfunction and the cellular 
mechanisms associated with the development of atherosclerotic lesions. In 1962, 
Schwartz and Mitchell showed that there was a positive correlation between the 
population of infiltrating cells in the adventitia and the advancement of the 
atherosclerotic plaque 15. However, little attention was paid to this study or others like 
this and efforts continued to focus on intima and luminal cell infiltration. There is now a 
growing belief that the adventitia plays a heavy role in regulating the remodeling of the 
vascular wall. Under vascular pathophysiological conditions, adventitial reactions are 
common, involving inflammation and increased collagen deposition within the adventitia 
and extending into the vascular wall and surrounding tissues 14. As previously mentioned, 
inflammatory cells migrate into the vascular wall through luminal endothelial cells; 
however, cells can infiltrate the adventitia through the vasa vasorum 15. Adhesion 
molecules such as P-selectin and vascular cell adhesion molecule 1 (VCAM-1) are 
upregulated within the vasa vasorum contributing to the accumulation of inflammatory 
cells within the adventitia making the adventitia a primary site for inflammation 16. 
Adventitial fibroblasts, the “first-responder” to vascular injury, are involved in normal 
maintenance of blood vessels, contributing to repair and remodeling 17. After tissue 
injury, adventitial fibroblasts are activated by cytokines released by inflammatory and 
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resident cells, migrate to the media and differentiate into myofibroblasts to synthesize 
extracellular matrix 18.  
 
1.4 Renal Artery and Vasculature 
 
1.4.1 Renal Artery and Vasculature Structure 
 The kidneys constitute less than 0.5% of total body weight but receive 20% of the 
cardiac output making it an extremely prominent organ, particularly within the 
cardiovascular system 19. The renal artery is an essential muscular artery supplying blood 
to the kidneys for blood filtration. The renal artery enters the kidney through the hilum, a 
prominent medial indentation that is the point of entry/exit for the kidney 20,6. The renal 
artery progressively branches into the interlobar, arcuate and interlobular arteries then to 
afferent arterioles prior to the glomerulus (Fig. 9) 20.  
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Figure 9: Diagram of the renal vasculature network. The renal artery enters the kidney 
and progressively branches into the segmental, interlobar, arcuate and interlobular 
arteries. From the arcuate artery, the blood flows into the afferent areriole and into the 
glomerulus for blood filtration. Then, it enters the efferent arteriole and into the 
peritubular capillaries where it transitions into the venous system. (From Chade, 2013) 
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 The glomerulus consists of a network of capillaries located in the renal corpuscle, 
which is the primary site of blood filtration. The renal corpuscle consists of the 
glomerulus and different supporting epithelial cells of the glomerular capsule also called 
Bowman’s capsule. The capsule is lined with a simple squamous capsular epithelium, 
which is continuous with the visceral epithelium that surrounds the glomerular capillaries 
where the capillaries are joined with the afferent and efferent arterioles at the vascular 
pole of the renal corpuscle 6. The visceral epithelium consists of large cells called 
podocytes wrapping around the capillaries with projection processes called pedicels. The 
pedicels interdigitate to create a fenestrated capillary network with narrow slits that 
allows for a high diffusion rate within the renal corpuscle. Podocytes are recognizable by 
their large and irregular nuclei (Fig. 10) 1. While podocytes play a central role in 
filtration, the mesangial cells act as pericytes and control the capillary blood flow 6. The 
mesangial cells are embedded within the mesangial or stalk region of the capillary 
network and contain actin-like filaments that enable them to contract and regulate blood 
flow 1,6.  
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Figure 10: (a) Diagram of the renal corpuscle displaying podocytes interdigitation. (b) 
Micrograph of renal corpuscle and surrounding tubules and structures. (From OpenStax 
College, 2013) 
 
 The kidney is unique in that it has a double capillary bed beginning in the 
capillaries of the glomerulus then joining in the efferent arterioles before entering the 
peritubular capillaries surrounding the renal tubules. After the peritubular capillaries, the 
blood vessels transition into the venous system and progressively into the renal vein, 
which exits the kidney through the hilum (Fig. 9) 20. 
 
1.4.2 Renal Blood Filtration 
 The renal corpuscle acts as a blood filter in which a pressure gradient allows 
water and ions to exit the capillary and enter the capsular space while retaining larger 
materials like red blood cells and plasma proteins 1. This diffused fluid is called filtrate 
and enters the renal tubule; a series of tubules that serve as sites for more secretion of 
waste products and reabsorption of nutrients and water in the filtrate prior to the 
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formation of urine. Together, the renal corpuscle and renal tubule form the functional unit 
of the kidney called the nephron 6. The renal tubule is composed of several regions of 
diversified morphology with two convoluted tubules, beginning with the proximal and 
ending with the distal, separated by a tubular loop called the nephron loop 1. The entrance 
to the proximal convoluted tubule is directly opposite of the afferent and efferent 
arterioles at the urinary pole of the renal corpuscle and is continuous with the Bowman’s 
Space. Each section of the renal tubule is a site of diffusion for water, ions (mainly Na+ 
and K+), toxins and organic nutrients with the peritubular capillaries around the nephron 
6. Nephrons’ renal corpuscles are mostly located in the superficial cortex of the kidney 
with the nephron loop dropping into the medulla.  
 
1.4.3 The Renin-Angiotensin-Aldosterone System 
 The kidney also plays a major role in cardiovascular regulation with its 
involvement in the renin-angiotensin-aldosterone system (RAAS). The RAAS is 
responsible for increasing sodium and fluid reabsorption when the body is deprived of 
sodium or water and is one of the main regulators of blood pressure 21,22. Juxtaglomerular 
cells of the kidney release the enzyme renin in response to a decrease in renal blood 
pressure, which begins an enzyme cascade in the bloodstream 6. Renin converts 
angiotensinogen to angiotensin I, which is then cleaved by angiotensin-converting 
enzyme (ACE) to create angiotensin II (Fig. 11) 21. Angiotensin II stimulates a number of 
effects including stimulating the production of aldosterone and antidiuretic hormone 
21 
 
causing increased sodium and water reabsorption in the kidneys, stimulating thirst to 
increase fluid intake and stimulating cardiac output and systemic vasoconstriction 6.  
 
Figure 11: Pathway of the RAAS and its effect on physiology and pathology. 
Angiotensin II has a direct effect on the vasculature inducing vasoconstriction. Indirectly, 
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angiotensin II induces increased sodium and fluid reabsorption in the kidneys through the 
release of aldosterone.  (From, et al., 2011) 
 
 In pathology, the RAAS is continuously activated under conditions such as 
hypertension, renal artery stenosis and diabetes, which can further disease progression 21. 
Systemic and glomerular hypertension contributes to the onset and progression of 
diabetic kidney disease 23. Angiotensin II and aldosterone contribute to insulin resistance 
by increasing oxidative stress and altering insulin-signaling 21. Intervention within the 
RAAS is a well-established therapeutic method in managing hypertension and diabetes to 
mitigate organ damage 23. ACE inhibitors and angiotensin receptor blockers have long 
been used to slow cardiovascular and renal damage by controlling hypertension 23,21. 
 
1.5 Diabetes Mellitus 
 
1.5.1 Prevalence of Diabetes 
 Diabetes mellitus is a group of metabolic diseases where blood glucose levels are 
elevated chronically due to ineffectual insulin production or response 24. Diabetes is 
reaching pandemic proportions with the number of people diagnosed with diabetes 
doubling in the past 20 years 25. The growing prevalence of diabetes is especially stark in 
developing countries as more people adopt western diets, and the governments of these 
nations cannot keep pace with the number of patients and cost of care. An estimated 425 
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million people worldwide, or 8.8% of adults, are considered to be diabetic with that 
number expected to grow to 629 million by 2045 24. There are several pathogenic 
processes that can contribute to the development of diabetes as detailed further below.  
 
1.5.2 Pancreas Anatomy & Physiology  
 The pancreas is an essential organ that possesses an exocrine and endocrine 
function. The exocrine function involves clusters of gland cells and their associated ducts 
that secrete enzyme-rich fluid used for digestion. The exocrine-related cells called acinar 
cells inhabit approximately 99% of the volume of the pancreas. Small clusters of cells 
scattered throughout the pancreas called the islets of Langerhans, perform the pancreatic 
endocrine functions. The pancreatic islets contain several types of hormone-producing 
cells denoted by alpha (α), beta (β), delta (δ) and gamma (γ). 
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Figure 12: Pancreas diagram. The acinar cells secrete digestive enzymes that are 
incorporated with bile secreted from the gallbladder and transported into the small 
intestine. The pancreatic islet is shown highlighting the alpha and beta cells and their 
respective produced hormones of glucagon and insulin. (From OpenStax College, 2013) 
 
 γ-cells produce pancreatic polypeptide that influences the activity of the 
gastrointestinal tract such as stimulating pancreatic enzyme release and inhibiting 
intestinal motility. δ-cells contain somatostatin, which suppresses the release of insulin 
and glucagon release. α-cells produce the metabolic hormone glucagon, which raises 
blood glucose levels through glycogen breakdown and glucose synthesis in the liver. 
Glucagon acts as the antagonist to the main anabolic hormone, insulin, which is produced 
by β-cells (Fig. 12) 6.  
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Figure 13: Regulatory pathway for management of blood glucose concentrations and the 
action of glucagon and insulin. (From Martini 4th ed., 1998)  
 
 Insulin is responsible for promoting the transport of glucose from the bloodstream 
into surrounding cells and the breakdown of the glucose into ATP 24. When blood 
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glucose levels rise, insulin is released to increase cellular glucose uptake in target cells, 
which include skeletal muscle and most organs. Cells that are considered insulin-
dependent and possess receptors on their plasma membranes for insulin to bind, which 
activate the cellular pathways for glucose transmembrane transport, glucose utilization, 
glycogen synthesis and other cellular anabolic pathways (Fig. 14) 26. 
 
Figure 14: Schematic showing effects of insulin binding on cellular pathways. (From De 
Meyts P, 2016) 
 
 
1.5.3 Pathology of Diabetes 
 Type 1 diabetes is caused by the destruction of the insulin-producing β-cells of 
the pancreas due to an autoimmune reaction. Type 1 accounts for approximately 5% to 
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10% of all cases of diabetes. The most common type of diabetes is type 2 diabetes, 
accounting for about 90% of diabetic patients. In Type 2 diabetes, there is a combination 
of pathological defects 3. One defect is the decreased ability of insulin to act on peripheral 
to stimulate glucose metabolism or inhibit glucose output. The other is the inability of the 
pancreatic β-cells to produce the amount of insulin needed to properly compensate for 
this insulin resistance 27. 
 
Figure 15: Development of type 2 diabetes. Insulin resistance is associated with obesity 
induced by adipokines, free fatty acids and chronic inflammation. Pancreatic β-cells are 
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stimulated to increase their synthesis and secretion of insulin to compensate. However, 
this leads to β-cell failure and cell death resulting in to diabetes induction. (From Kumar, 
et al. 8th ed., 2010) 
 
 With a deficient supply of insulin or ineffective insulin, hyperglycemia is a 
defining characteristic of the disease 28. While the epidemiology of type 2 diabetes is well 
understood, the management of the disease still poses a major challenge to clinicians and 
patients 25. If not properly managed, the chronic hyperglycemia of diabetes can cause 
other conditions to develop including long-term organ dysfunction, damage and failure as 
well as pathological cardiovascular remodeling 28.  
 
1.5.4 Diabetes Connection to Vascular Disease 
 Diabetes is a major risk factor for vascular pathology, increasing the likelihood 
for cardiovascular disease by 2-4 fold due to accelerating atherosclerotic plaques and 
vascular stiffening, the hallmark of diabetes 29,30. Diabetes, which affects the vascular 
wall at the cellular and extracellular level, exacerbates and accelerates the development 
of atherosclerosis. At the cellular level, the endothelium is injured under insulin-
resistance conditions as cells decrease their secretion of NO and increase their production 
of endothelin-1 and ROS leading to endoplasmic reticulum stress and apoptosis; 
processes that accelerate the early stages in atherosclerosis. In the media, hyperglycemia 
stimulates the inflammatory synthetic phenototype of SMCs and heightens their 
migration and proliferation 11,31. Fibroblasts of the adventitia are affected by diabetes as 
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they are also stimulated to proliferate and migrate to the media and intima contributing to 
medial SMC hypertrophy, neointimal growth, plaque thickening and fibrous cap 
formation 32,14. At the extracellular level, the major vascular matrix components interact 
with the elevated levels of blood glucose, lipids and AGEs via oxidation and crosslinking 
processes. AGEs are formed when a protein or lipid interacts with glucose through a non-
enzymatic nucleophilic addition reaction between a free amino group and the reducing 
sugar carbonyl group forming reversible early glycation products and Schiff bases before 
transitioning to Amadori products 29,30.  
 
Figure 16: Biochemical pathways of oxidation and cross-linking processes due to fatty 
acids and glucose. (Image courtesy of Dhulekar et al., 2018) 
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 The rearrangement of the Schiff base into the Amadori product is called the 
Maillard reaction and results in an irreversible crosslink between vascular wall proteins, 
collagen and elastin, leading to vascular stiffening 34. By the induction of crosslinking, 
AGEs trap lipoproteins in the vascular wall accelerating atherosclerotic plaque formation 
35. The process of AGE formation is dependent on the amount of glucose in the 
bloodstream and is accelerated in diabetes due to the hyperglycemic environment 34. 
AGEs have a receptor on endothelial cells termed RAGE, which is active in normal and 
pathologic states. AGEs are found in plasma but accumulate in the vessel wall in diabetes 
with their abundance and their interaction with RAGE. This interaction with the 
endothelium induces the expression of VCAM-1, which binds circulating leukocytes to 
vessel wall 29. This leads to chronic inflammation, which is the common link between 
diabetes and atherosclerosis. The mechanisms for the development of atherosclerosis are 
not fully understood, but it is thought of as a response-to-injury model. 
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Figure 17: American Heart Association classification of evolution and progression of 
human atherosclerotic lesions. The characteristic types of the lesion are enumerated on 
the left of the flow diagram. From I to IV, the lesion progression consists mainly of lipid 
deposition. The loop between IV and VI is a repetitive process illustrating how lesions 
increase in thickness. (From Stary et al., 1995) 
 
 It is a chronic inflammatory and healing response to an endothelial injury that 
evolves through the interactions of lipid deposits, leukocytes and normal cellular 
components of the vascular wall. The genesis of atherosclerosis begins with the initiation 
of a chronic endothelial injury on the vessel wall that includes hypertension, 
dyslipidemia, hyperglycemia or other hemodynamic factors that activate the endothelial 
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cells, which initiates the inflammatory cell recruitment cascade 3. Once endothelial 
activation occurs, chronic inflammation is promoted by recruiting platelets and 
leukocytes, mainly circulating monocytes and lymphocytes, to attach to and migrate 
through the endothelium 30. The adhered monocytes migrate to the intima where they are 
differentiated into macrophages. With chronic dyslipidemia, lipoproteins accumulate in 
the intima and become oxidized by oxygen free radicals generated by macrophages and 
endothelial cells. These oxidized lipoproteins are ingested by macrophages and become 
laden with the accumulation of lipids. The lipid-filled macrophages are called foam cells 
and are rendered useless while attributing to the accumulation within the atherosclerotic 
lesion. Growth factors and cytokines released by activated platelets, endothelial cell and 
macrophages promote SMC migration and proliferation in the intima and ECM 
deposition 3. The fatty streak lesion progresses into a complex, occlusive lesion with 
layers of futile leukocytes and SMCs, lipids and necrotic debris surrounded by ECM 
proteins called a fibrous plaque (Fig. 18) 36.  
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Figure 18: Diagram showing the progression of an atherosclerotic lesion. Beginning with 
the induction of a chronic endothelial injury (1), endothelial dysfunction is induced 
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leading to increased permeability, platelet adhesion and leukocyte adhesion and 
migration (2). Accumulation of differentiated macrophages and migrated SMCs from 
media within the intima occurs forming a neointima (3). Lipids are engulfed by 
macrophages forming foam cells with lipids accumulating in the intima (4). A fibrous cap 
is formed by extracellular matrix-depositing SMCs growing into the luminal space 
severely inhibiting blood flow (5). (From Kumar, et al., 2005) 
 
1.5.5 Diabetes and Renal Disorders 
 Diabetes is also the most common cause of chronic renal disorders including 
kidney fibrosis, diabetic nephropathy, chronic kidney disease and end stage renal disease. 
Approximately a third of type 1 diabetics and a half of all type 2 diabetics develop 
chronic kidney disease 37. Diabetes affects kidney function in a series of stages as 
diabetic nephropathy develops 38. The onset of diabetes results in an elevated glomerular 
filtration rate and the size of the kidneys increases by approximately 20% 39,38. After the 
hyperfiltration stage, the glomerular filtration rate begins to regress back to normal levels 
while microalbuminuria, an increase in the amount of the plasma protein albumin in the 
urine, develops suggesting the onset of nephropathy. From there, the glomerular filtration 
rate falls to levels that are synonymous with chronic kidney failure and proteinuria 
develops. Glomerular filtration rate and proteinuria are the best indicators for the 
progression of the disease, and once chronic kidney failure develops, the damage and 
reduced function are irreversible 38.  
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1.5.6 Role of Pericytes in Renal Pathology 
 Pericytes are present in all vascularized tissue including in the kidney and play a 
significant role in the functionality of the kidney. Subsets of renal pericytes with distinct 
functionalities have been identified including renin-secretion of the pericytes of the 
juxtaglomerular arterioles that control blood flow to the glomeruli, mesangial cells, 
which support the glomerular structure, and glioma-associated oncogene-expressing 
pericytes, which contribute to fibrosis 19.  
 
Figure 19: The juxtaglomerular complex and glomerulus. (From Shaw, et al., 2018) 
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 The upregulation of signaling pathways such as TGF- β and PDGF induces the 
proliferation and differentiation of pericytes into myofibroblasts 40. It has been suggested 
that renal perictyes possess multiple tissue-regenerative properties that are phenotypic of 
mesenchymal stem cells, and pericytes have been shown to be precursors to these 
multipotent cells 19. Pericytes show this regenerative potential in injured skeletal muscle, 
ischemic heart tissue, gone and adipose tissue and with their prevalence in all 
vascularized tissue, serve as local reservoirs of regenerative cells 41.  
 
1.5.7 Myofibroblasts in Renal Pathology 
 Fibrosis is a normal part of wound healing and repair to maintain the original 
tissue architecture and function. An infiltrative response from pro-inflammatory cells 
such as monocytes/macrophages, lymphocytes and mast cells into injured tissue is 
required to stimulate tissue repair through the release of fibrogenic cytokines 23. 
Myofibroblasts are reactive cells that are stimulated under pathological conditions to 
deposit ECM. Because fibrosis is the final common pathway of several renal diseases, 
myofibroblasts have increasingly become a cell of interest in renal pathology 7. 
Myofibroblasts are contractile and are identifiable by their expression of α-SMA, the 
actin isoform characteristic of vascular SMCs 42. α-SMA forms bundles of myofilaments 
called stress fibers that exert mechanical forces when the cell contracts causing matrix 
reorganization 7. Myofibroblasts are considered the main collagen-producing cells 
synthesizing interstitial ECM components such as collagen type 1 and III in wound 
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healing, cancer and organ fibrosis 43,44. Myfibroblasts are commonly associated with 
pathology as they are rarely found in normal tissue and are terminally differentiated from 
multiple cell types 44. The role and functionality of myofibroblasts is well understood; 
however, their origin is a more unknown subject 43. Pericytes and perivascular adventitial 
fibroblasts have been shown as the primary source for myofibroblast differentiation in 
kidney fibrosis 45.  
 
Figure 20: Fibroblast induction and differentiation into myofibroblasts. (From Meran, et 
al., 2011) 
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 However, other studies have shown pericytes do not contribute to kidney fibrosis, 
and that most myofibroblasts are derived from resident tissue fibroblasts, and to a lesser 
degree, endothelial and epithelial cells. Bone marrow-derived cells can differentiate into 
myofibroblasts under the influence of TGF-β. As seen with vascular SMCs de-
differentiating and gaining a fibroblast-like phenotype producing ECM, resident tissue 
fibroblasts can proliferate and gain a contractile functionality 43. Although their precise 
origin is debated, the differentiation into myofibroblasts is considered one of the key 
cellular events in the development of organ fibrosis 43,42.  
 
1.5.8 Renal Morphological Changes Induced by Diabetes 
 A wide range of morphological changes in renal tissue can be attributed to diabetes 
such as glomerular sclerotic lesions, hypertrophy of glomeruli, tubule-interstitial fibrosis, 
tubular hypertrophy, increased expression of myofibroblasts and inflammation that 
contribute to kidney dysfunction and diabetic nephropathy 46. Glomerular basement 
thickening is the first measurable morphological change caused by diabetes with tubular 
basement membrane thickening quickly ensuing 47. This is due to the increased rates of 
synthesis for basement proteins such as laminin, collagen type IV and fibronectin due to 
diabetes particularly during the beginning phases of the disease 48. Hypercellularity of the 
glomerulus is a common characteristic of inflammatory responses associated with a 
systemic disease like diabetes including an infiltration of leukocytes within the 
glomerulus and the peritubular capillaries 3. In addition, mesangial cells tend to divide 
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and proliferate in certain kidney disease 1. In type 2 diabetes, mesangial expansion is a 
major morphological change preceding loss of renal function 47. The severity of the 
morphological changes to the glomeruli are proportional to glomerular filtration rate, 
diabetes duration and blood glucose regulation 38. 
 
1.6 Tissue Engineering as a Solution to Diabetes-induced Remodeling 
 
1.6.1 Challenges and Solutions 
 
 With the extensive pathological remodeling that occurs in diabetic vasculature and 
kidneys, it is important to fully understand the cellular and extracellular mechanisms 
behind the tissue remodeling. This is of particular importance in tissue engineering, 
where the goal is to replace or repair the damaged tissue with a replacement that is 
resistant to the pathophysiological conditions preventing further tissue deterioration 49. 
With blood vessel tissue-engineered replacements, a biodegradable or biocompatible 
scaffold that mimics the wall properties of the native vessel is seeded with autologous 
stem cells prior to implantation. Additionally, the graft can be conditioned prior to 
implantation to condition the wall to the local environment and allow for remodeling and 
graft maturation 29. These tissue-engineered grafts present various challenges including 
non-thrombogenicity, adequate burst pressure and compliance, inflammatory responses, 
appropriate remodeling responses and vasoactivity 50. For diabetic patients, an additional 
challenge is the aggressive oxidative environment generated by the hyperglycemia and 
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dyslipidemia characteristic of diabetes that induces inflammation, tissue degeneration and 
impaired tissue remodeling 29.  
 
Figure 21: Diagram of the process behind a tissue-engineered vascular graft. A porcine 
blood vessel is harvested and decellularized to act as a scaffold. Stem cells are harvested 
from the patient and cultured, propagated and seeded onto the scaffold. The graft can then 
be conditioned chemically and mechanically for maturation in a bioreactor as needed 
prior to implantation. (Image courtesy of Dhulekar et al., 2018) 
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 With the direct dependence the kidneys have on the vascular system, their 
morbidities are commonly associated and are also a target for tissue engineering 
therapies. Revascularization is a critical part of graft acceptance for replacement vessels 
and kidneys of the replacement graft in order to support and sustain the graft components. 
In blood vessels, complete tissue integration and vasa vasorum formation are essential for 
graft acceptance 51. The mechanisms behind the development of the renal 
microvasculature are not fully understood but thought to arise from angiogenesis or 
during kidney development 49. Kidney decellularization offers a unique solution to this 
problem by providing a biological scaffold to be recellularized with host cells to provide 
functionality and no immune response from the host. This method preserves the structural 
components of the kidney including the collagen, elastin, laminin and fibronectin of the 
vasculature and basement membrane. Recellularization presents another challenge to 
overcome for successful graft. This typically involves a constant infusion of cells in an in 
vitro setting such as a bioreactor 52.  
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Figure 22: General representation for the decellularization and recellularization process 
for a functional kidney. (From Destefani, et al., 2017) 
 
  
1.6.2 Need for Improved Therapies 
 With the degenerative effects on the vasculature and kidneys associated with 
diabetes, solutions are needed to mitigate these risks and improve patient outcomes. 
When a patient’s renal function declines to end stage renal disease levels, their treatment 
options are essentially limited to dialysis and transplantation. While dialysis does 
decrease mortality, it has significant limitations including morbidity, convenience and 
cost. Allogenic transplantation is the optimal treatment with benefits in mortality and 
cost-saving but is limited by the scarcity of available donated organs 53. Renal 
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pathologies also accelerate the progression of cardiovascular disease. In patients with end 
stage renal disease, cardiovascular mortality is 15 to 30 times higher than the age-
adjusted cardiovascular mortality in the general population. The relationship between 
renal function and cardiovascular mortality also applies to people with more moderate 
degrees of impaired renal function 2.  
 While advances have been made in vascular graft technology resulting in declining 
arterial disease-related mortality, this improvement has not been observed in diabetics 29. 
Diabetic patients have been shown to have a higher incidence of restenosis with drug-
eluting stents and occlusions in coronary artery bypass grafting using a saphenous vein at 
1-year 54,55. With these challenges to synthetic grafts, the current “gold standard” of 
vascular grafts are autologous vessels such as the internal thoracic artery and saphenous 
vein 56. However, about 1/3 of patients (approximately 140,000 each year) do not have 
vessels suitable for grafting due to age or systemic vascular disease 29. Synthetic grafts 
are used an alternative to autologous grafts, but these promote more challenges to 
properly mimic the mechanical and biological functions of a native vessel. Synthetic 
vascular grafts with large and medium diameters have shown promise with long-term 
patency rates; however, synthetic grafts are not suitable for smaller diameter vessels 
(<6mm) as occlusion occurs far too quickly 57.  
 The field of tissue engineering has proven to have great potential in vascular graft 
and organ regeneration. In order to develop tissue-engineered replacements resistant to 
the alterations induced by a diabetic environment, it is essential for the modifications of 
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the native tissue to be elucidated. The aim of this study is to histologically analyze the 
morphological changes of renal tissue associated with diabetes with an emphasis on 
remodeling of the vasculature and to use these findings to better utilize tissue engineering 
to mitigate damaging morphological alterations due to diabetes. 
 
 
2 Materials and Methods 
2.1 Animal Model 
 The diabetic animal model was developed as described before 58. Briefly, adult 
male Sprague Dawley rats (n=40, weight 300–350 g) were rendered diabetic via a single 
dose of sterile filtered 55 mg/kg streptozotocin (STZ) solution in 0.1 M citrate buffer (pH 
5) by tail vein injection (day zero). Control rats (n=40) received an equal volume of 
vehicle (sterile citrate buffer). Starting on day 3, levels of blood glucose in all diabetic 
rats were determined 3–4 times per week, using AlphaTRAK (Gen II) test strips on the 
AlphaTRAK Blood Glucose Monitoring System, designed specifically for animals. 
Glycemia levels were also assayed weekly in the control, non-STZ treated rats. Diabetes 
was established (>400 mg glucose/dL blood), and diabetic rats were given subcutaneous 
injections of long-lasting insulin (2–4 U Isophane) every other day to maintain blood 
glucose level in a desirable range (400–600 mg glucose/dL blood) and prevent develop-
ment of ketonuria and weight loss. Control rats exhibited mean glycemic levels of 128+/-
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12 mg glucose/dL blood. Glucose levels, individual weights, hydration status, and food 
and water consumption were monitored closely to ensure adequate health parameters. 
Animals were provided with food and water ad libitum and were cared for by the 
attending university veterinarian and associated staff at the Godley-Snell Research Center 
animal facility at Clemson University. The Animal Research Committee at Clemson 
University approved the animal protocol (AUP 2011-002), and National Institute of 
Health (NIH) guidelines for the care and use of laboratory animals (NIH publication #86–
23 Rev. 1996) were observed throughout the experiment. The experimental animals used 
in this study were part of an abdominal-aortic graft trial as this study was a subsidiary 
study of a vascular graft trial. The grafts used in the trial were decellularized porcine 
arteries with half being treated with penta-galloyl glucose (PGG), an elastin stabilizing 
agent, and half untreated. These grafts were implanted in non-diabetic and diabetic rats 
with one rat being left as a control.  
2.2 Tissue Collection 
 At 3 months, the animals were euthanized, and the kidney samples were 
explanted. At the point of extraction, the kidneys were bilaterally sectioned along the 
hilus using a scalpel. This was done to ensure proper tissue fixation due to the kidney’s 
dense fibrous cortex makes it difficult for formalin to penetrate into the renal tissue. Each 
sample was then washed with phosphate-buffered saline to remove all blood and placed 
immediately in 10% neutral buffered-formalin upon explant. The samples were left in 
formalin for 48 hours to allow for tissue fixation before proceeding to tissue processing.  
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2.3 Sample Processing 
 The samples were properly processed using a graded alcohol procedure in the 
tissue processor and paraffin-embedded. The embedded samples were sectioned at 6 μm 
using a microtome. The sections were placed on a warm water bath before placing them 
on a microscope slide. The microscope slides were left to dry on a slide warmer before 
placing them in an oven at 56°C for 30 minutes to properly adhere the section to the 
slide. The sample cross sections underwent various histological stains for analysis.  
 For each staining procedure, the samples were deparaffinized and rehydrated 
through the following procedure: 3x5 min in xylene, 2x5 min in 100% ethanol, 2x4 min 
in 95% ethanol, 3 min in 85% ethanol, 3 min in 70% ethanol, 3 min in 50% ethanol, 
dipping in tap water until the alcohol sheet is gone and 3 min in DI water. 
 
2.4 Hematoxylin & Eosin Stain 
 To observe glomerular remodeling, cellular interactions and tubular remodeling, 
hematoxylin & eosin (H&E) staining was used. Sections were deparaffinized as described 
above and were then stained in hematoxylin for 6.5 min then placed in running water to 
wash away excess hematoxylin. This was followed by 6 dips in Clarifier then again 
dipping in tap water until the alcohol sheet is gone. Then, the samples were immersed in 
Bluing reagent for 1 min followed by tap water for 1 min. Then, placed in 10 dips of 95% 
ethanol to dehydrate before staining with eosin for 45 seconds. The samples were then 
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dehydrated again before cover slip mounting by the following procedure: 2x10 dips in 
95% ethanol, 10 dips in 100% ethanol, 2x2 min in 100% ethanol, 5 min in xylene and 5 
min in xylene.  
 
2.5 Glomerular Basement Membrane Thickening Analysis 
 Periodic Acid Schiff (PAS) Stain was used to determine the extent of glomerular 
basement membrane thickening. After deparaffinization, the slides were immersed in 
Periodic Acid Solution for 10 min then rinsed in four changes of distilled water. The 
slides were then immersed in Schiff’s Solution for 30 min before rinsing in hot running 
tap water. Next, the slides were stained in Modified Mayer’s Hematoxylin for 3 min and 
rinsed in running tap water for 3 min. The slides were then placed in Bluing Reagent for 
30 sec before being rinsed in distilled water and dehydrated to xylene before coverslip 
mounting.  
 
2.6 Perivascular Fibrosis Analysis 
 Perivascular fibrosis of the renal vasculature was analyzed using Masson’s 
Trichrome (MT) stain (Poly Scientific). The samples were deparaffinized and rehydrated 
before placing in Bouin’s Fixative at 56°C for 1 hour. The samples were then cooled and 
washed in running water until the yellow color disappeared from the samples. After, the 
samples were stained in Weigert’s Iron Hematoxylin Working Solution for 10 min then 
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washed in running water for 10 min before rinsing with DI water. They were then stained 
in Biebrich Scarlet Acid Fuchsin for 2 min and rinsed again in DI water. Next, they were 
placed in Phosphotungstic Phosphomolybdic Acid for 15 min then Aniline Blue Solution 
for 5 min. The samples were then rinsed with DI water and placed in Acetic Acid 1% 
Aqueous for 5 min before proceeding to dehydrating and mounting.  
 
2.7 Macrophage Localization 
 To determine the extent of inflammation within the kidney, macrophage 
localization was performed through immunohistochemistry (IHC) using the anti-CD68 
antibody (ab955 - Abcam). The CD68 antibody is a heat-mediated antibody; therefore, 
the samples were placed in a pressure cooker at 320°C for 5 min with 160 mL of citrate 
buffer in 1440 mL of DI water (pH 6.0). This was followed by 3 rinses and 3 washes for 
5 min with DI water. Blocking was done through endogenous peroxidase with 0.3% H2O2 
in 0.3% normal serum in Tris-buffered saline (TBS) for 10 min. The sections were rinsed 
twice with 0.025% Triton for 5 min to permeabilize the cellular membranes and then 
repeated the TBS rinse and wash cycle. The sections were incubated in normal serum for 
20 min to block unspecific blocking sites. The sections were then blotted before applying 
the primary antibody made in Tris-NaCl-blocking (TNB) buffer. For this CD68 antibody, 
the antibody was diluted to 1:100 TNB buffer. Negative controls only received TNB 
buffer. The samples were incubated overnight at 4°C with the primary antibody. The TBS 
rinse and washing cycles were repeated before the secondary antibody was applied. The 
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secondary antibody was made using 30 μL of normal blocking serum in 2 mL TBS and 
10 μL of biotinylated anti-mouse IgG. The secondary antibody was applied for 1 hour at 
room temperature and then rinsed and washed in TBS. Avidin/Biotinylated enzyme 
Complex (R.T.U. Vectastain ABC Reagent – Vector Laboratories, Inc.) was applied for 
30 min at room temperature and then rinsed and washed in TBS. The samples were then 
developed for 3-5 min with a DAB substrate solution (DAB Peroxidase Substrate Kit – 
Vector Laboratories, Inc.) consisting of 5 mL of DI water, 2 drops of Buffer Stock 
Solution, 4 drops of DAB Stock Solution, 2 drops of H2O2 and mixed well. The time for 
development was determined by checking the samples under a microscope for proper 
exposure. The samples were rinsed and washed in TBS then placed in tap water for 5 min 
before counterstaining in hematoxylin for 2 min. The samples were then dehydrated 
following the procedure previously described and mounted.  
 
2.8 Myofibroblast Localization 
 Myofibroblast localization was performed through IHC using the anti-α-SMA 
antibody (ab5694 - Abcam) to determine the extent of kidney fibrosis progression. 
Antigen retrieval was done through heat-mediation, the primary antibody was diluted at a 
concentration of 1:200 TNB buffer and required a rabbit secondary antibody. Otherwise, 
the procedure is the same as described above.  
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2.9 Basement Membrane Thickening   
 Tubule-interstitial basement membrane thickening was analyzed using anti-
collagen type IV antibody (ab6586 – Abcam). Antigen retrieval was done through heat-
mediation, the primary antibody was diluted at a concentration of 1:500 TNB buffer and 
required a rabbit secondary antibody.  
 
2.10 Pericyte Localization 
 Pericyte localization was performed through IHC using the CD146 antibody 
(ab75769 - Abcam) to determine if there was an upregulation of proliferation and 
migration of pericytes. Antigen retrieval was done through heat-mediation, the primary 
antibody was diluted at a concentration of 1:200 TNB buffer and required a rabbit 
secondary antibody.  
 
2.11 Endothelial Cell Localization 
 Endothelial cells were localized using an anti-von Willebrand Factor (vWF) 
antibody (ab6994 - Abcam) to determine if repair and remodeling was occurring through 
angiogenesis. This antibody requires antigen retrieval through 0.1% Proteinase K in TBS 
applied to the sections for 40-60 seconds. The primary antibody was diluted at a 
concentration of 1:250 TNB buffer and required a rabbit secondary antibody.  
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2.12 Histological Quantification and Statistical Analysis 
 Micrographs of the stained kidney sections were taken to draw observable 
conclusions and generate quantifiable data. Using an image processing software 
(ImageJ), particle density was measured by setting the color hue to the appropriate range 
for the color of interest. This range was kept constant for all images of each respective 
staining while the saturation and brightness of the image was variable for each image to 
diminish noise. The particle density measurement was generated as a percent area of the 
image, and the mean percent area was calculated for the non-diabetic and diabetic groups 
for each staining. A t-test was performed to determine statistical significance between 
non-diabetics and diabetics for all quantified data sets. 
 
3 Results 
 
 The animal weights were maintained within 25% of their starting weight for the 
duration of the study. Diabetic rats blood glucose level were maintained at or above 400 
mg/dl for the duration of the study (Fig. 23).  
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Figure 23: Graph showing weights and blood glucose values of rats over time.  
 
 
Figure 24: Explanted kidney samples. 
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3.1 Glomeruli Alterations 
 The glomerulus consists of an anastomosing network of capillaries lined with 
fenestrated endothelium. The glomerular basement membrane consists of collagen type 
IV, laminin, polyanionic proteoglycans and several glycoproteins. Using histological 
analysis of the kidney, we show that glomeruli are altered under diabetic conditions, 
compared to non-diabetic environments. H&E staining shows that the glomeruli are 
modified in diabetic animals  (Fig. 25 and 26). Blood components are more infiltrated in 
the diabetic kidney as the basement membrane are fenestrated endothelial cells are 
injured. Furthermore, PAS staining, specific for proteoglycans and glycoproteins, shows 
the thickening of the glomerular basement membrane in diabetes (Fig. 27). Both stains 
highlight the hypercellularity characteristic of glomerular disease. 
 
Figure 25: Non-diabetic glomeruli stained with H&E. These glomeruli exhibited no 
observable alterations.  
54 
 
 
Figure 26: Diabetic glomeruli stained with H&E. Diabetic glomeruli exhibited 
hypercellularity of the mesangium (A,C), potential glomerular sclerotic lesions (D), 
hyperfiltration (A,B), loss of the Bowman’s space (A,B,D) and possible collapse of the 
capillary bed (B).  
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Figure 27: Micrographs of non-diabetic (left) and diabetic glomeruli (right) stained with 
PAS. There is a heavier deposit of magenta in the diabetic glomeruli proving there is a 
thickening of the glomerular basement membrane.  
 
3.2 Perivascular Fibrosis Quantification 
 MT was used for perivascular fibrosis analysis. MT stains nuclei – black, collagen 
– blue and cytoplasm and muscle fibers – red.  Micrographs were taken of non-diabetic 
and diabetic renal arterial blood vessels of ranging sizes.  All blood vessels analyzed had 
to be a true lateral cross-section of the vessel to avoid skewed measurements. ImageJ was 
then used to measure the luminal diameter and vessel wall thickness and to analyze the 
Diabetic Non-Diabetic 
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particle density of blue (collagen) between the blood vessel and the renal tissue (Table 1).  
A two-sample t-test was performed at α=0.05 to determine statistical significance 
between the percent concentration of collagen of non-diabetic and diabetic blood vessels. 
The average wall thickness and the concentration of perivascular collagen were both 
found to be statistically significant between the non-diabetic and diabetic population.  
 
 
Figure 28: Perivascular fibrosis in non-diabetics (above) and diabetics (below). All 
images shown above have been stained with Masson’s Trichrome. Non-diabetic samples 
can be seen on the top row. Sparse collagen deposits can be seen around all non-diabetic 
blood vessels. Diabetic samples can be seen on the bottom row. (A) and (B) have a 
luminal diameter of <60 µm and a collagen percentage of 12.5% and 31.5%, respectively. 
(C) and (D) have a luminal diameter of >60 µm and a collagen percentage of 16.5% and 
29.7%, respectively. (E) and (F) have a luminal diameter of >100 µm and a collagen 
percentage of 18.4% and 38.5%, respectively. A heavier concentration of collagen and 
interstitial ingrowth of collagen can be seen in all diabetic samples. 
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Table 1: Perivascular Fibrosis Quantification 
Sample 
Type 
Luminal 
Diameter 
Range (Sample 
Size) [µm] 
Avg. Luminal 
Diameter 
(Range) [µm2] 
Avg. Wall 
Thickness 
(µm) 
Avg. Area 
of Interest 
(µm2) 
Avg. Area 
of  Collagen 
(µm2) 
Non-
Diabetic 
<60 (n=11) 41.87 (19.5-
56.4) 
15.91 12987 2057 
>60 (n=10) 93.76 (61.3-
129.6) 
22.96 33477 5621 
All (n=21) 66.58 19.26 22744 3754 
Diabetic 
<60 (n=12) 39.87 (23.7-
58.2) 
26.46 19278 5101 
>60 (n=9) 104.34 (61.6-
135.8) 
29.20 34573 8349 
All (n=21) 64.43 27.63 25105 6338 
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Figure 29: Analysis of average wall thickness between non-diabetic (Blue) and diabetic 
(Red) animals organized by luminal diameter (Top). Analysis of concentration of 
collagen surrounding the blood vessels (Bottom). This was calculated by measuring the 
amount of blue color and dividing it by the total area of interest (area within where the 
fibrous capsule of the blood vessel meets the renal tissue). 
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Table 2: p-values (α=0.05) for Average Wall Thickness and Perivascular Collagen 
Concentration 
Vessel Luminal Diameter Avg. Wall Thickness Collagen Concentration 
<60 µm 1.13x10-5 7.50x10-6 
>60 µm 0.031 0.036 
All Vessels 1.70x10-5 8.46x10-7 
 
 
3.3 Inflammation Assessment 
 As previously described, pro-inflammatory cell infiltration is a precursor to 
chronic remodeling and fibrosis as they release growth factors and activators to 
endothelial cells and fibroblasts to alter their phenotype. Therefore, if inflammatory cells 
are present, chronic remodeling and fibrosis is likely to follow. To assess the degree of 
inflammation within the kidney, IHC was performed with anti-CD68 antibody to localize 
infiltrating macrophages. CD68 is a specific marker for macrophages. Images taken from 
diabetic samples can be seen below (Fig. 30).  
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Figure 30: Micrographs of diabetic kidneys stained with anti-CD68 antibody localizing 
macrophages. This shows an increased infiltration of macrophages within the renal 
vasculature.  
  
3.4 Tubular Basement Membrane Thickening Assessment 
 In addition to the vasculature, the tubulointerstitium was analyzed for remodeling 
and collagen deposition. The metabolic consequences of diabetes like hyperglycemia 
induce tubular remodeling and increased collagen deposition. To determine the degree 
tubular basement membrane thickening, IHC was performed using anti-collagen type IV 
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antibody. Collagen type IV is the main protein in the glomerular basement membrane and 
Bowman’s capsule and stains a light brown color.  
  
  
Figure 31: Micrographs of non-diabetic kidneys stained for collagen type IV. No 
deposits of collagen were seen within the tubulointerstitium space. 
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Figure 32: Diabetic kidney sections stained for collagen type IV. Collagen deposits 
(Brown) can be seen within the tubulointerstititum space in the cortex (A, C, D) and 
medulla (B).  Heavier deposits could also be seen within the glomerular basmement 
membrane and Bowman’s capsule (A, C, D). 
 
3.5 Myofibroblast Localization 
 Fibrosis is a normal part of wound healing and repair to maintain the original 
tissue architecture and function as well as during pathological remodeling. To determine 
the degree of kidney fibrosis, kidneys were stained for α-SMA, the main protein 
expressed by contractile cells. Myofibroblasts are reactive cells that are stimulated by 
cytokines and growth factors released by pro-inflammatory cells under pathological 
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conditions to deposit ECM. Myofibroblasts utilize α-SMA and are the main collagen 
depositors in organ fibrosis; therefore, myofibroblast activity is a good marker for kidney 
fibrosis progression.  
 
Figure 33: Non-diabetic kidney sections stained for α-SMA. No deposits of α-SMA were 
seen in the tubulointerstitium space. Deposits were seen in blood vessels, which is a well 
established outcome and was expected. 
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Figure 34: Diabetic kidney sections stained for α-SMA. Increased deposits could be 
throughout the renal tissue (A). Deposits could be seen within the renal tubules showing 
tubule degeneration with increased myofibroblast activity (C,D). 
 
3.6 Pericyte Localization 
 Pericytes are particular cells of interest in vascular dysfunction, as they serve as a 
support for the endothelial cells but also have mesenchymal stem cell properties. CD146 
is a specific marker for pericytes. Using anti-CD146 antibody, we show the accumulation 
of pericytes in diabetes as the number of capillaries is increased, leading to infiltration of 
inflammatory cells and cells involved in fibrosis and pathological remodeling.   
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Figure 35: Non-diabetic kidney (A,C) and diabetic kidney sections (B,D) stained with 
CD146 antibody. Increased pericyte expression could be seen in the tubulointerstitium 
space in diabetics when compared to non-diabetics (A,B) and within the glomeruli (C,D). 
 
 
3.7 Endothelial Cell Localization 
 vWF is a glycoprotein released by endothelial cells into circulation that is 
involved in arterial thrombus formation. vWF is upregulated under risk factors such as 
cardiovascular disease and diabetes or when endothelial cells dysfunction occurs 59. vWF 
was used as a marker for endothelial cells. 
Non-Diabetic Diabetic 
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Figure 36: Non-diabetic (A,C) and diabetic kidneys (B,D) stained for von Willebrand 
Factor. Heavier positive staining deposits can be seen in diabetics in the 
tubulointerstitium space (B) and within the glomeruli (D).  
 
 
3.8 IHC Quantification 
 ImageJ was used to quantify the amount of positive binding in each of the five 
IHC stains done. For collagen type IV, α –SMA, CD146 and vWF, the entire area of 5 
non-diabetic kidney and 5 diabetic kidney sections were imaged at a magnification of 
25X with each image quantified. This was done by particle analyzing the brown area and 
Non-Diabetic Diabetic 
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calculating the percent area of the brown in relation to the total area of each image. For 
the kidney sections stained for macrophages with CD68, localized macrophages were 
found in the sections and their percent area was quantified. This was done because the 
particles cannot be analyzed at a low magnification and required a higher magnification 
(100X). The average percent area for non-diabetics and diabetic are listed for each of the 
five antibodies used as well as the standard deviations and p-values (Table 2). A two-
sample t-test was performed for each staining and each were found to be statistically 
significant at α=0.01. 
Table 3: Average Percent Areas for IHC  
Sample Type COLL IV α -SMA CD146 vWF CD68 
 
Non-
Diabetic 
Avg. Percent 
Area (%) 
0.3783 
(n=58) 
0.3595 
(n=51) 
0.2975 
(n=55) 
0.4068 
(n=46) 
0.1369 
(n=14) 
Standard 
Deviation 
0.2481 0.1442 0.1343 0.2312 0.0677 
 
Diabetic 
Avg. Percent 
Area (%) 
0.9456 
(n=54) 
0.8920 
(n=49) 
0.5631 
(n=24) 
0.5691 
(n=43) 
0.2591 
(n=30) 
Standard 
Deviation 
0.3690 0.3605 0.1942 0.3096 0.1370 
p-value (α=0.01) 1.45x10-15 2.96x10-14 3.64x10-7 3.34x10-3 1.43x10-4 
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 Figure 37: Quantification of IHC staining results.  
 
4 Discussion 
 
 Alterations to the structure of glomeruli were visible in the diabetic population. 
While the sections stained hematoxylin & eosin were not quantified, they were used to 
gain general observations about renal remodeling. Hematoxylin stains nucleic acids a 
deep purple color while eosin unspecifically stains proteins pink 60 Potential 
hyperfiltration, mesangial cell proliferation, developing glomerular sclerotic lesions and 
glomerular hypertrophy were observed (Fig. 26). To confirm these observations, PAS 
was used, which stains basement membrane components such as polysaccharides and 
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mucosubstances. A heavier deposit of these substances (magenta) could be seen in 
mesangium confirming the thickened glomerular basement membrane (Fig. 27).  
 Dense perivascular collagen deposition was seen under diabetic conditions. This 
was confirmed with quantification of the collagen deposits with non-diabetic and diabetic 
blood vessels having an area collagen percentage of 16.1% and 25.4%, respectively. The 
diabetic blood vessels analyzed had a smaller luminal diameter and thicker vessel wall 
than the non-diabetic blood vessels displaying the narrowing of the lumen that is 
characteristic of arteriosclerosis (Table 1, Fig. 29).  The difference between non-diabetics 
and diabetics for average arterial wall thickness and perivascular collagen concentration 
were both found to be statistically significant at α=0.05 (Table 2). 
 The average percent area for all IHCs were found to be statistically significant at 
α=0.05 between diabetics and non-diabetics (Fig. 37) (Table 3). Within the 
tubulointerstitium, increased collagen deposition was confirmed. A type IV collagen 
layer could be seen in the interstitial space between the renal tubules in diabetics while 
none was observed in non-diabetics (Fig. 31, 32). Increased collagen type IV was also 
ssen within the glomerular basement membrane and Bowman’s capsule (Fig. 32). An 
increased presence of macrophages was seen in diabetics (Fig. 30). This is evidential by 
the sample size for number of images between non-diabetics (n=14) and diabetics (n=30). 
Infiltration of proinflammatory cells is a key event in not only inflammation but also lead 
to repair as these cells release cytokines and growth factors that target cells that promote 
remodeling including fibroblasts, endothelial cells and pericytes should also be increased. 
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Therefore, if macrophages are upregulated, cells involved in wound healing and tissue 
remodeling should also be more prevalent. Increased myofibroblast activity was observed 
in diabetic kidneys with heavy deposits of α-SMA in the medulla and sparse deposits 
within cortex and glomeruli (Fig. 34). This is evidential of advancing kidney fibrosis – a 
common outcome in diabetic nephropathy. Pericytes and endothelial cells were in greater 
abundance in diabetics in the medulla and within the glomeruli (Fig 35, 36). Both of 
these vascular cell types are migratory and major contributors in angiogenesis. Their 
increased presence shows that increased repair and remodeling is occurring in diabetic 
kidneys.  
 
5 Conclusion 
 
 The results of this study show that there is increased chronic repair and 
pathological remodeling within diabetic kidneys in a short-term model. Given the 
remodeling observed in the diabetic kidneys, the mechanism behind the response and 
repair of the kidneys was important to be elucidated first before developing tissue-
engineered replacements. In conclusion, determining the modifications induced by 
diabetes at a vascular cell and extracellular level could lead to finding optimal treatments 
for renal artery disease and improved kidney tissue engineering approaches. 
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6 Limitations and Future Work 
 
 Given the short timetable for the animal model in this study, a long-term animal 
model is needed to observe and quantify the definitive effects on the kidneys due to a 
diabetic environment. This animal model used was also an abdominal aorta graft model. 
Further work would involve analyzing the remodeling of the renal artery in a diabetic 
environment. This could be accomplished in an in vitro model utilizing a bioreactor to 
mimic the hemodynamic forces and hyperglycemia of a diabetic environment.  
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